Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MC...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2025-12-01
Saila:	Annals of Clinical and Translational Neurology
Gaiak:	Alzheimer's disease cognitive worsening mild cognitive impairment plasma biomarkers plasma p‐tau181 subjective cognitive decline
Sarrera elektronikoa:	https://doi.org/10.1002/acn3.70190
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!